Emerald Advisers’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-611,525
| Closed | -$5.47M | – | 265 |
|
2021
Q4 | $5.47M | Buy |
611,525
+45,797
| +8% | +$410K | 0.2% | 112 |
|
2021
Q3 | $9.39M | Sell |
565,728
-3,335
| -0.6% | -$55.4K | 0.34% | 99 |
|
2021
Q2 | $11.8M | Buy |
569,063
+14,784
| +3% | +$307K | 0.43% | 91 |
|
2021
Q1 | $10.4M | Buy |
554,279
+38,555
| +7% | +$723K | 0.38% | 103 |
|
2020
Q4 | $11.4M | Buy |
515,724
+10,649
| +2% | +$234K | 0.38% | 99 |
|
2020
Q3 | $10.5M | Buy |
505,075
+103,744
| +26% | +$2.15M | 0.43% | 80 |
|
2020
Q2 | $14.5M | Buy |
401,331
+92,378
| +30% | +$3.34M | 0.63% | 60 |
|
2020
Q1 | $10.1M | Buy |
308,953
+281,688
| +1,033% | +$9.21M | 0.58% | 66 |
|
2019
Q4 | $744K | Buy |
27,265
+17,121
| +169% | +$467K | 0.03% | 161 |
|
2019
Q3 | $111K | Buy |
+10,144
| New | +$111K | 0.01% | 240 |
|